The Forest Deal was in the works for atleast six months, if not a year, waiting for FDA approval. Q was a fall back position for Clinical Data. Forest is going to put on thousands of their reps on Virbryd. The thought that Clinical Data was only going to put 150 reps to sell a new AD? Total joke! And if people who interviewed for this job were not smart anough to listen to what Clinical Data said on the conference call after Viibryd was approve, and understand that 150 reps for a new AD was a joke, than they deserve to be disappointed.
